- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00288886
Reinforcement of Abstinence and Continuing Care in Substance Abuse Treatment
Reinforcement of Abstinence and Attendance in Substance Abuse Treatment
Study Overview
Status
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
Mississippi
-
Jackson, Mississippi, United States, 39216
- G.V. (Sonny) Montgomery VA Medical Center, Jackson, MS
-
-
Virginia
-
Salem, Virginia, United States, 24153
- Salem VA Medical Center, Salem, VA
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Participants were recruited from consecutive veterans who successful complete the 28-day SARRTP at the Salem VAMC and the 21-day SARRTP at the Jackson VAMC. Participants who are uninterested in aftercare, who have unstable housing or other factors that made aftercare participation difficult, will be included to maximize the generalizability of our results.
Exclusion Criteria:
Individuals who did not live within a 60-minute drive, and those who did not have transportation and a work schedule allowing attendance of aftercare were ineligible.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Contracts, Prompts and Reinforcement arm
Participants were provided with contracting, prompting and reinforcement of continuing care attendance and substance use abstinence.
|
Contracting, prompting and reinforcement of continuing care and abstinence.
|
Active Comparator: Control Arm
Participants were provided with routine care- they did not receive contracting, prompting and reinforcement of continuing care attendance and substance use abstinence.
|
Routine residential treatment and orientation to continuing care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Abstinence Rate (During the Preceding 90 Days) at 12 Months Follow-up Point as Assessed by the Form-90
Time Frame: Assessed at 12 months
|
Participants who were abstinent was assessed via Form-90 Interview (Form 90I) is a structured interview that assesses substance use and related behaviors over the previous 90 days employing a calendar-based follow-back method that provides continuous measures of substance use, and has good reliability.
Measures include days abstinent, days using alcohol, days using drugs, total number of standard drinks, and days of self help meeting attendance.
Briefer versions were constructed to collect data via telephone in instances when participants did not return for in-person interviews.
As a reliability check on participants' self-report, a collateral interview was employed when contacting informants.
Participants who denied use on the Form-90, but had a positive substance use screen were considered to be not abstinent for that follow-up point.
|
Assessed at 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Abstinence Rate (During the Preceding 90 Days) at 3- and 6-months Follow-up Point as Assessed by the Form-90
Time Frame: Assessed at 3 and 6 months
|
Participants who were abstinent was assessed via Form-90 Interview (Form 90I) is a structured interview that assesses substance use and related behaviors over the previous 90 days employing a calendar-based follow-back method that provides continuous measures of substance use, and has good reliability.
Measures include days abstinent, days using alcohol, days using drugs, total number of standard drinks, and days of self help meeting attendance.
Briefer versions were constructed to collect data via telephone in instances when participants did not return for in-person interviews.
As a reliability check on participants' self-report, a collateral interview was employed when contacting informants.
Participants who denied use on the Form-90, but had a positive substance use screen were considered to be not abstinent for that follow-up point.
|
Assessed at 3 and 6 months
|
Days Until First Use of Alcohol or Drugs
Time Frame: Baseline to 12 months
|
Baseline to 12 months
|
|
Aftercare Attendance
Time Frame: Assessed at 3-, 6-, 9-, and 12-months
|
Measures of aftercare attendance include: Percentage of participants who attended at least 1 aftercare session; percentage of participants who attended at least 2 aftercare sessions/month for at least 3, 6, 9 and 12 months; and percentage of participants who passed the VAMC's SUD continuity of care performance measure (a benchmark for retention of clients in aftercare for at least two visits each month for 3 months following initial treatment)
|
Assessed at 3-, 6-, 9-, and 12-months
|
Self-help Support Group Attendance
Time Frame: Assessed over the past 90 days at 3, 6 and 12 months, and cumulative over 1 year
|
Assessed over the past 90 days at 3, 6 and 12 months, and cumulative over 1 year
|
|
Days of Substance Abuse (Across the Prior 90 Days)
Time Frame: Assessed at Baseline, 3-, 6-, and 12-month follow-up
|
Assessed at Baseline, 3-, 6-, and 12-month follow-up
|
|
Rates of Hospitalization (Across the Prior 90 Days)
Time Frame: Assessed at Baseline, 3-, 6-, and 12-months
|
Number of days hospitalized for any reason per the previous 90 days
|
Assessed at Baseline, 3-, 6-, and 12-months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Steven J Lash, PhD, Salem VA Medical Center, Salem, VA
Publications and helpful links
General Publications
- Lash SJ, Timko C, Curran GM, McKay JR, Burden JL. Implementation of evidence-based substance use disorder continuing care interventions. Psychol Addict Behav. 2011 Jun;25(2):238-51. doi: 10.1037/a0022608.
- Lash SJ, Burden JL, Parker JD, Stephens RS, Budney AJ, Horner RD, Datta S, Jeffreys AS, Grambow SC. Contracting, prompting and reinforcing substance use disorder continuing care. J Subst Abuse Treat. 2013 Apr;44(4):449-56. doi: 10.1016/j.jsat.2012.09.008. Epub 2012 Oct 31.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IIR 03-267
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alcoholism
-
Yale UniversityCompletedFamilial Alcoholism VulnerabilityUnited States
-
Yonsei UniversityTerminated
-
Yale UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)RecruitingFamilial Alcoholism VulnerabilityUnited States
-
University of Southern DenmarkActive, not recruitingGeneral Practice | Alcohol Abuse Alcoholism | Screening and Brief InterventionDenmark
-
University of FloridaNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedEffects of Family History of Alcoholism and Sex on Alcohol AnalgesiaUnited States
-
Brown UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedAlcoholic Liver Disease | Alcoholism,United States
-
Khoo Teck Puat HospitalNot yet recruitingEmergencies | Alcohol Use Disorder | Alcoholism and Alcohol Abuse
-
National Institute on Drug Abuse (NIDA)The Peter G. Dodge Foundation (PGDF)Completed
-
Virginia Commonwealth UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA); Yale University; University...CompletedAlcoholismUnited States
-
University of Sao PauloCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.; Conselho Nacional... and other collaboratorsEnrolling by invitation
Clinical Trials on Contracting, Prompting and Reinforcement arm
-
US Department of Veterans AffairsDuke University; Virginia Polytechnic Institute and State UniversityCompletedSubstance Dependence | Treatment Outcome | ComplianceUnited States
-
Arizona State UniversityShanghai Xuhui Clover Children Healthy Garden; Jingdezhen Kindkids Autism Rehabilitation... and other collaboratorsTerminated
-
Cwm Taf University Health Board (NHS)PRIME Centre WalesUnknown
-
Northwestern UniversityParker B. Francis Fellowship ProgramCompleted
-
Hospital do CoracaoD'Or Institute for Research and Education; Sociedade Hospital SamaritanoCompleted
-
Comenius UniversityUniversity Hospital, MartinActive, not recruiting
-
University of UtahNational Institute of Nursing Research (NINR)Completed
-
W.L.Gore & AssociatesTerminatedRectal Cancer | Ulcerative Colitis | Familial Adenomatous Polyposis | DiverticulitisUnited States
-
National Development and Research Institutes, Inc.National Institute on Drug Abuse (NIDA)CompletedCigarette SmokingUnited States
-
University of PennsylvaniaCompleted